enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Sanofi - Wikipedia

    en.wikipedia.org/wiki/Sanofi

    Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...

  3. Sanofi Pasteur - Wikipedia

    en.wikipedia.org/wiki/Sanofi_Pasteur

    2004: merger of Aventis with and into Sanofi. The new Sanofi-Aventis Group becomes the world's 3rd largest pharmaceutical company, behind Pfizer and GlaxoSmithKline. Aventis Pasteur, the vaccine division of the Sanofi-Aventis Group, changes its name to Sanofi Pasteur. 2008: Sanofi Pasteur acquires Acambis plc, a biotech company.

  4. Why Sanofi Stock Was Robustly Healthy Today - AOL

    www.aol.com/why-sanofi-stock-robustly-healthy...

    Although the latest news from the laboratory was mixed for pharmaceutical company Sanofi (NASDAQ: SNY) on Tuesday, investors gave the company the benefit of the doubt. They bid the share price up ...

  5. Rhône-Poulenc - Wikipedia

    en.wikipedia.org/wiki/Rhône-Poulenc

    Rhône-Poulenc (French pronunciation: [ʁon pulɛ̃k]) was a French chemical and pharmaceutical company founded in 1928.In 1999, it merged with Hoechst AG to form Aventis.As of 2015, the pharmaceutical operations of Rhône-Poulenc are part of Sanofi and the chemicals divisions are part of Solvay group and Bayer Crop Science.

  6. Why Sanofi Stock Flew Higher on Friday - AOL

    www.aol.com/finance/why-sanofi-stock-flew-higher...

    No investor can ignore a crushing bottom-line beat and raised profitability guidance.

  7. Sanofi CEO believes company poised for growth from new drugs

    www.aol.com/news/sanofi-ceo-still-considering...

    NEW YORK (Reuters) -Sanofi's chief executive, Paul Hudson, said in an interview on Monday that the company is poised for strong growth from a variety of new drugs and is not facing imminent ...

  8. Sanofi CEO under pressure to woo investors after ... - AOL

    www.aol.com/news/analysis-sanofi-ceo-under...

    (Reuters) -Sanofi's CEO is under pressure to tell investors how much more he will spend on research and development (R&D) and what the likely pay-offs will be, as he seeks to boost a pipeline of ...

  9. A. Nattermann - Wikipedia

    en.wikipedia.org/wiki/A._Nattermann

    In December 1999, the latter merged with Hoechst AG to form a new company called Aventis, which in turn was acquired by Sanofi in December 2004. Since then, Nattermann has belonged to Sanofi . Under the direction of Sanofi, Nattermannallee today employs 440 people producing 100 million packages of medicines annually.